Recent Updates
Recently added Catalysts

MARVEL algorithm

Phase 1

Atrioventricular Conduction Block | Unknown | Other |Rhythm Pharmaceuticals, Inc.|Last Updated: Oct 26, 2018

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials1
Total Enrollment70
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT03157297Micra Atrial Tracking Using a Ventricular Accelerometer StudyPHASE1 COMPLETED 70Jul 10, 2017Nov 24, 2017Oct 26, 201813 United States, Austria +7
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Atrioventricular synchrony
Initial 24 hour period after patient enrollment

On an individual heartbeat basis, this is defined as a right ventricular paced or sensed R-wave associated with an ECG confirmed P-wave.

MARVEL Evolve Substudy
Initial 24 hour period after patient enrollment

Characterize the rate of atrioventricular synchrony provided by the MARVEL algorithm and compare the accelerometer signal amplitudes and the AV synchrony provided by the MARVEL algorithm with the data collected during the initial MARVEL procedure.

Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeDEVICE_FEASIBILITY
Treatment Arms
ArmTypeDescription
EnrolledEXPERIMENTALSubjects enrolled in the MARVEL study. Enrolled subjects will have the MARVEL algorithm downloaded into their implanted market released Micra device.
Interventions
NameTypeDescription
MARVEL algorithmDEVICESoftware download into implanted Micra device
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites13

Inclusion Criteria: * Subject has been implanted with, or is expected to be implanted with a MicraTM TPS (Model MC1VR01), with remaining device longevity of 6 years or more. * Subject is ≥ 18 years old and as per required local law. * Subject has atrioventricular (AV) block. * Subject (and/or witne...

Countries:United StatesAustriaBelgiumCzechiaDenmarkFranceItalyMalaysiaSpain
Unlock Eligibility Criteria